Trial Profile

Clinical Trials Insight: 700036982

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 May 2009

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PSN 821 (Primary)
Indications Obesity; Type 2 diabetes mellitus
Focus Adverse reactions

Most Recent Events

12 May 2009 Results reported in an OSI Pharmaceuticals media release. Results are also expected to be presented together with the second phase I trial (trial profile 700044736) at a scientific session.
12 May 2009 According to an OSI Pharmaceuticals media release, data from this trial was used to support progression of PSN821 into a 14-day trial (see trial profile 700044736).
12 May 2009 Status changed from recruiting to completed, according to an OSI Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com